habener glp-1 Joel Receives Breakthrough Prize in Life Sciences for Contributions to Medications QnAs with Svetlana Mojsov, Joel
Description
The MHRA continues to monitor the safety profile of Wegovy
Thats not just a few poundsfor someone weighing 200 pounds, thats potentially 30-40 pounds of sustainable weight loss
When clinicians apply structured monitoring strategies, they can preserve the powerful metabolic benefits of GLP-1 receptor agonists while minimizing safety concerns
This pressure was felt slightly more by women (62%) than men (59%) and increased in younger generations (Gen Z: 64%, millennials: 67%, Gen X: 55%)
